LGMD-2E/R4
Showing 26 - 50 of >10,000
Newly Diagnosed Asymptomatic High-Risk Chronic Lymphocytic
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- EQ-5D-5L Instrument
- +2 more
-
Vancouver, British Columbia, Canada
- +3 more
Dec 12, 2022
Heart Failure With Preserved Ejection Fraction Trial in Porto (Dapagliflozin, Spironolactone, Spironolactone + Dapagliflozin)
Recruiting
- Heart Failure With Preserved Ejection Fraction
- Dapagliflozin
- +2 more
-
Porto, Portugal
- +1 more
Jan 12, 2023
Cheek Wrinkles, Midface Contour Deficiencies Trial in Canada (GP0112, Restylane Lyft Lidocaine)
Recruiting
- Cheek Wrinkles
- Midface Contour Deficiencies
- GP0112
- Restylane Lyft Lidocaine
-
Calgary, Alberta, Canada
- +14 more
Jul 22, 2022
Critical Illness Trial in Canada (Albumin Fluid Resuscitation Optimization Intervention, Usual Practice)
Completed
- Critical Illness
- Albumin Fluid Resuscitation Optimization Intervention
- Usual Practice
-
Calgary, Alberta, Canada
- +14 more
Oct 31, 2022
Brodalumab in Plaque Psoriasis to Understand Impact on Quality
Recruiting
- Psoriasis
- Brodalumab
- Matched cohort
-
Calgary, Alberta, Canada
- +33 more
Oct 8, 2022
Non-melanoma Skin Cancer, Carcinoma, Squamous Cell, Carcinoma, Basal Cell Trial in Canada (Nicotinamide, Placebo)
Not yet recruiting
- Non-melanoma Skin Cancer
- +3 more
- Nicotinamide
- Placebo
-
Calgary, Alberta, Canada
- +7 more
Jul 13, 2023
Depressive Disorder, Treatment-Resistant Trial in Edmonton, Halifax (Repetitive Transcranial Magnetic Stimulation (rTMS),
Not yet recruiting
- Depressive Disorder, Treatment-Resistant
- Repetitive Transcranial Magnetic Stimulation (rTMS)
- Repetitive Transcranial Magnetic Stimulation (rTMS) Plus Text4Support
-
Edmonton, Alberta, Canada
- +1 more
Dec 16, 2022
Bietti's Crystalline Dystrophy Trial in Beijing (ZVS101e)
Recruiting
- Bietti's Crystalline Dystrophy
-
Beijing, Beijing, ChinaPeking University Third Hospital
Feb 2, 2023
LGMDR9 Trial in Copenhagen, Paris, Newcastle Upon Tyne (GNT0006, Day 0: Placebo, Day 0: GNT0006)
Recruiting
- LGMDR9
- GNT0006
- +4 more
-
Copenhagen, Denmark
- +2 more
Oct 21, 2022
FGFR Testing by Either ctDNA Blood Testing or Standard Tumor
Recruiting
- Metastatic Bladder Cancer
- Metastatic Urothelial Carcinoma
- FGFR Testing
-
Calgary, Alberta, Canada
- +6 more
Nov 8, 2023
Prostate Cancer Trial in Vancouver, Montreal, Quebec City (177Lu-PSMA-617, Docetaxel)
Suspended
- Prostate Cancer
-
Vancouver, British Columbia, Canada
- +3 more
Jun 13, 2022
COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)
Recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901a
-
Halifax, Nova Scotia, Canada
- +6 more
Nov 16, 2022
Crohn's Disease Trial in Edmonton (Synbiotic, Digestible Maltodextrin)
Recruiting
- Crohn's Disease
- Synbiotic
- Digestible Maltodextrin
-
Edmonton, Alberta, Canada
- +4 more
Jan 10, 2023
Alzheimer Trial in Canada (Montelukast buccal film, Placebo buccal film)
Recruiting
- Alzheimer Disease
- Montelukast buccal film
- Placebo buccal film
-
Victoria, British Columbia, Canada
- +12 more
Jul 21, 2022
Natural History Study for Charcot Marie Tooth Disease
Recruiting
- Charcot-Marie-Tooth Disease
- +47 more
-
New York, New YorkHereditary Neuropathy Foundation
Jun 12, 2023
Pneumococcal Vaccines Trial in Canada (IVT PCV-25 Formulation A, IVT PCV-25 Formulation B, IVT PCV-25 Formulation C)
Not yet recruiting
- Pneumococcal Vaccines
- IVT PCV-25 Formulation A
- +3 more
-
Vancouver, British Columbia, Canada
- +3 more
Oct 10, 2023
HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following
Active, not recruiting
- HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
- Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
- Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
-
Calgary, Alberta, Canada
- +24 more
Sep 12, 2022
Pancreatic Adenocarcinoma Trial in Canada (Gemcitabine, Nab-paclitaxel, Durvalumab)
Active, not recruiting
- Pancreatic Adenocarcinoma
- Gemcitabine
- +3 more
-
Calgary, Alberta, Canada
- +26 more
May 9, 2022
Depression, Anxiety, Quality of Life Trial in Winnipeg (Focused ACT)
Active, not recruiting
- Depression
- +3 more
- Focused ACT
-
Winnipeg, Manitoba, Canada
- +2 more
Nov 1, 2022
Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in
Recruiting
- DCIS
-
Victoria, British Columbia, Canada
- +9 more
Jan 31, 2023
Infection Trial in Canada (Fecal Microbiota Transplantation (FMT))
Suspended
- Infection
- Fecal Microbiota Transplantation (FMT)
-
Brampton, Ontario, Canada
- +12 more
Nov 1, 2022
Metastatic Cancer Trial in Canada (Stereotactic Ablative Radiotherapy (SABR), Standard of Care Treatment)
Active, not recruiting
- Metastatic Cancer
- Stereotactic Ablative Radiotherapy (SABR)
- Standard of Care Treatment
-
Edmonton, Alberta, Canada
- +6 more
Aug 22, 2022
Chin Augmentation and Correction Trial in Canada (Hyaluronic Acid)
Completed
- Chin Augmentation and Correction
- Hyaluronic Acid
-
Calgary, Alberta, Canada
- +8 more
Jun 21, 2022